The Role of anti-VEGF in certain retinal diseases. Corneal Diseases. affecting Cataract outcomes.
Date: 2/04/2019
Venue: 28/12 Railway Parade, Burwood , NSW, 2134
Provider: INSERVIO PTY LTD
Contact: INSERVIO PTY LTD, [E] Tina.Xenoulis@inservio.com.au, [P] 0432808708
Learning Objectives
- Identify certain retinal diseases
- Understand treatment and management of certain retinal diseases
- Understand the importance and the role of anti-VEGF treatment in certain Retinal Deiseases
- Identify certain corneal diseases
- Understand how corneal disease can impact the outcome of cataract surgery
- Best protocol and management for certain corneal diseases and whether cataract surgery will be beneficial.
- Understand the role and effectiveness of Femtosecond laser
- The use of Femtosecond laser in catarct surgery
- Identify suitable candidates for Femtosecond laser
Max points awarded: 7.00
Session Information
Name |
---|
Ant-VEGF treatment in Certain Retinal Diseases highlighting Lucentis in Myopic CNV |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
3.00 |
Name |
---|
Case Studies on Corneal Diseases which affect Cataract surgery outcomes |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
3.00 |
Name |
---|
The use of Femtosecond Laser in cataract Surgery |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Ant-VEGF treatment in Certain Retinal Diseases highlighting Lucentis in Myopic CNV | Face to Face with Assessment | No | No | 3.00 |
Case Studies on Corneal Diseases which affect Cataract surgery outcomes | Face to Face with Assessment | Yes | No | 3.00 |
The use of Femtosecond Laser in cataract Surgery | Face to Face without Assessment | No | No | 1.00 |